Author:
Haba Yuichiro,Shiga Takayoshi,Naito Toshio
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Pharmaceutical interview form Mydrin®-P ophthalmic solution (11th edition, July 2017). Santen Co., Ltd, Osaka, Japan [in Japanese]. http//image.packageinsert.jp/pdf.php?mode = 1&yjcode = 1319810Q1053. Accessed 24 Nov 2018.
2. Hamasaki I, Hasebe S, Kimura S, et al. Cycloplegic effect of 0.5% tropicamide and 0.5% phenylephrine mixed eye drops: objective assessment in Japanese schoolchildren with myopia. Jpn J Ophthalmol. 2007;51(2):111–5.
3. Rengstorff RH, Doughty CB. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Am J Optom Physiol Opt. 1982;59(2):162–77.
4. Sbaraglia F, Mores N, Garra R, et al. Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia. Paediatr Anaesth. 2014;24(4):400–5.
5. Labetoulle M, Frau E, Jeunne CL. Systemic adverse effects of topical ocular treatments. Presse Med. 2005;34(8):589–95.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phenylephrine/tropicamide;Reactions Weekly;2019-03